Document is current
Any future updates will be listed below
-
Authors
Hamilton, Erika https://orcid.org/0000-0002-1911-0336
Layman, Rachel M. https://orcid.org/0000-0002-8663-0331
Cosgrove, David
Danso, Michael
Zhang, Hui
He, Wei
Kim, Su Young
Fan, Jie https://orcid.org/0009-0003-5497-0512
Patel, Manish R.
-
Funding
Funding for this research was provided by:
This study was funded and sponsored by Accutar Biotechnology Inc.
- License Information
-
More Information
Article History
Received: 19 August 2025
Accepted: 1 December 2025
First Online: 17 December 2025
Competing interests
: The authors declare the following competing interests. D.C. and M.P. have no relevant disclosures to declare. H.Z., W.H., S.Y.K., and J.F. are employees of Accutar Biotechnology Inc. R.L. has received research support from Accutar Biotechnology, Eli Lilly, Puma, Celcuity, Arvinas, Biotheryx, and Boundless Bio, participated in advisory boards for Eli Lilly, Novartis, Celcuity, Gilead, and Biotheryx, and received honoraria from Pfizer. M.D. has worked in consulting or advisory roles for Novartis, Pfizer, Immunomedics, Seattle Genetics, Agendia, AstraZeneca, bioTheranostics, Genentech, Gilead Sciences, Lilly, Stemline Therapeutics, and Puma Biotechnology. E.H. has received research funding from Abbvie, Accutar Biotechnology, Artios, Arvinas, AstraZeneca, AtlasMedx, BeiGene, Bicycle Therapeutics, Biohaven Pharmaceuticals, BioNTech, Compugen, Cullinan, Daiichi Sankyo, Dantari, Day One Biopharmaceuticals, Duality Biologics, Ellipses Pharma, Elucida Oncology, Exelixix, FujiFilm, Genmab, Gilead Sciences, H3 Biomedicine, Iambic Therapeutics, Immunogen, Inspirna, InventisBio, Jacobio, Jazz Pharmaceuticals, K-Group Beta, Kind Pharmaceuticals, Lilly, Loxo Oncology, Mabspace Biosciences, Mabwell Bioscience, Marengo Therapeutics, MediLink Therapeutics, Merck, Mersana, Novartis, Olema, Orinove, Orum Therapeutics, Pfizer, Pionyr Immunotherapeutics, Prelude Therapeutics, Profound Bio, Regeneron, Relay Therapeutics, Rgenix, Roche/Genentech, SeaGen, Shattuck Labs, Simcha Therapeutics, Stemline Therapeutics, Sutro, Systimmune, Taiho, Tesaro, TheRas, Treadwell Therapeutics, Verastem, Xadcera Biopharmaceutical, Zymeworks, and has had consulting/advisory roles with Arvinas, AstraZeneca, BeOne Medicines, Boehringer Ingelheim, Boundless Bio, Bristol-Myers Squibb, Circle Pharma, Daiichi Sankyo, Gilead Sciences, Halda Therapeutics, Incyclix Bio, IQVIA, Janssen, Jazz Pharmaceuticals, Jefferies LLC, Johnson and Johnson, Lilly, Mersana Therapeutics, Novartis, Pfizer, Precede Biosciences, Pyxis Oncology, Roche/Genentech, Samsung Bioepis, Shorla Pharma, Stemline Therapeutics, and Tempus Labs.
